Background Systemic hypertension confers a hypercoagulable state. We hypothesized that resting mean blood pressure (MBP) interacts with stress hormones in predicting coagulation activity at rest and with acute mental stress.
Introduction
Virchow's triad of thrombogenesis posits that changes in the vessel wall (e.g. endothelial dysfunction with atherosclerosis), blood flow (e.g. stasis), and blood constituents (e.g. coagulation activation) together contribute to arterial thrombosis [1] . Hypertensive individuals showed elevated levels of coagulation factors and von Willebrand factor (VWF) in plasma, as well as hyperactive platelets on the one hand, and impaired fibrinolysis on the other, compatible with a hypercoagulable state [2] . A number of hemostasis molecules, also increased in hypertension, are now viewed as 'new' risk factors of coronary artery and cerebrovascular disease [3, 4] . In particular, meta-analyses demonstrate that fibrinogen [5] , VWF [6] and D-dimer [7] , the latter indicating activation of the entire coagulation system, independently predict coronary artery disease. These data support the notion that the hypercoagulable state in hypertension is of clinical relevance because it could contribute to the increased risk of atherothrombotic events (e.g. myocardial infarction and stroke) in hypertensive individuals [8] .
The pathophysiological underpinnings of the hypercoagulable state in hypertension are not fully understood, though target organ damage and endothelial dysfunction might be involved. Fibrinogen and VWF levels relate to left ventricular hypertrophy [9] and nephropathy [10] , respectively. Moreover, elevated blood pressure (BP) is a strong risk factor for atherosclerosis [11] which is characterized by an early decline in endothelial function [12] . In hypertension, increased plasma levels of endothelium-derived VWF indicate endothelial damage [13] . The endothelium is crucial in regulating blood flow by providing an active antithrombotic surface and by secreting antithrombotic factors into the bloodstream [14] . If perturbed, the endothelium loses its ability to neutralize procoagulant processes, giving rise to a shift in the hemostatic balance between prothrombotic and antithrombotic forces towards hypercoagulability [14] .
We aimed to investigate whether hyperactivity of the sympathetic nervous system (SNS) and of the hypothalamic-pituitary-adrenal (HPA) axis would also contribute to procoagulant activity with elevated BP. The reasoning behind this investigation is twofold. First, sympathetic activation by acute mental stress or as mimicked by catecholamine infusions, elicits hypercoagulability [15] , and increased HPA axis activity [16] and exogenously administered glucocorticoids [17] also provoked hypercoagulability. Second, the SNS as evidenced by increased muscle sympathetic nerve activity or catecholamine turnover is hyperactive in hypertensives as opposed to normotensives [18] . This difference is not restricted to resting (i.e. steady state) SNS activity but is also observed in the response to sympathetic challenge [19] . For instance, hypertensives showed greater platelet activity [20] and reduced stress-induced fibrinolysis activation [21] in comparison to normotensives. Subtle hyperactivity of the HPA axis has also been postulated in hypertension [22] . However, whether catecholamine or cortisol reactivity contributes to prothrombotic changes in hypertensives has not been investigated.
Elevated BP predicts atherosclerotic risk along a continuum of severity [11] and systolic BP and diastolic BP are both predictive of cardiovascular morbidity [23] . In order to alleviate the risk of random associations with separate analyses for systolic BP and diastolic BP, we therefore investigated the linear relationship between mean blood pressure (MBP) and coagulation measures. We hypothesized that MBP would affect the relationship between resting and stress-induced levels of plasma catecholamines and of salivary free-cortisol and plasma levels of clotting factors VII (FVII:C), VIII (FVIII:C), fibrinogen and D-dimer in a sample of hypertensive and normotensive subjects. We selected these coagulation measures because we recently found them to be responsive to acute psychosocial stress in a group of healthy and normotensive middle-aged men [24] other than those included in the present study. Granted that stress axes are more active with higher BP [18, 19, 22] and that sympathetic activation kindles procoagulability in a dose-response manner [24] [25] [26] , we assumed a mechanism by which elevated stress hormones with higher MBP promote greater coagulability at rest, in response to acute stress, and during recovery from stress. The novel aspect of our investigation was therefore to examine in one study whether hormones of both stress axes have a specific effect on different coagulation factors in relation to resting blood pressure level.
Methods

Study participants
The Ethics Committee of the State of Zurich, Switzerland, formally approved the research protocol. The final study sample consisted of 48 subjects who provided written informed consent. With the aid of the Swiss Red Cross, Zurich and by advertisement, we recruited non-smoking hypertensive and normotensive men who, other than having hypertension, were in excellent physical and mental health, confirmed by an extensive health questionnaire [16] and telephone interview. Specific exclusion criteria, obtained by subjects' selfreport, were: regular heavy exercise, alcohol and illicit drug abuse; any heart disease, varicosis or thrombotic diseases, elevated blood sugar and diabetes, elevated cholesterol, liver and renal diseases, chronic obstructive pulmonary disease, allergies and atopic diathesis, rheumatic diseases and current infectious diseases. In addition, participants were included only if they reported taking no medication, either regularly or occasionally. If the personal or medication history was not conclusive, the subjects' primary care physician was contacted for clarification.
Assessment of hypertension
Three seated BP measurements were obtained by sphygmomanometry after a rest of 5 min on three different days, and the average BP was computed. Following World Health Organization criteria, hypertension was defined as systolic BP ! 140 mmHg and/or diastolic BP ! 90 mmHg [27] . Average MBP was calculated across all individuals using the formula [2/3(diastolic BP)þ1/3 (systolic BP)].
Stress protocol
Subjects were tested between 1400 and 1600 h. They had abstained from physical exercise, alcohol and caffeinated beverages since the previous evening. We used the Trier Social Stress Test (TSST) combining a 5-min preparation phase followed by a 5-min mock job-interview, and 5-min mental arithmetic before an audience [28] . The TSST evokes reliable physiological responses in different systems, including coagulation factors investigated in the present study [24] . During recovery, subjects remained seated in a quiet room for 60 min.
Heart rate (HR) was followed continuously via a portable monitor (Polar system, S810; Polar, Finland) and means were computed immediately before stress (i.e. average of 5 min), during stress (i.e. average of speech and arithmetic HR) and 20 min thereafter. Blood pressure was measured immediately before and 20 min after stress by sphygmomanometry, and continuously during stress (i.e. average of speech and arithmetic BP) by the Vasotrac APM205A device (Medwaves Inc., St. Paul, Minnesota, USA) respectively. Stress measures are presented after adjustment to sphygmomanometry readings following methods described previously [24] .
Blood for coagulation measures was obtained immediately before stress, immediately after stress, and 20 and 60 min after stress. At these time points and additionally at 10 min after stress, blood was drawn to determine catecholamine levels. For cortisol measurements, saliva samples were obtained at rest, immediately after stress and every 10 min thereafter.
Coagulation assays
Venous blood was drawn through an indwelling forearm catheter into polypropylene tubes containing 3.8% sodium citrate. Centrifugation was at 2000 Â g for 20 min at 48C. The plasma obtained was immediately aliquoted in polypropylene tubes and frozen at À808C. All analyses of coagulation factors used the BCS Coagulation Analyser (Dade Behring, Liederbach, Germany). Determination of FVII:C and FVIII:C used standard coagulometric methods using factor-deficient standard human plasma and reagents (Dade Behring) and plasma fibrinogen was determined using a modified Clauss method (Multifibren U; Dade Behring). Plasma D-dimer was measured by means of an enzyme-linked immunosorbent assay (Asserachrom Stago, Asniè res, France). Inter-and intra-assay coefficients of variation (CVs) were <10% for all coagulation measures.
Stress hormone assays
Venous blood for measuring catecholamines was drawn into EDTA-coated monovettes (Sarstedt, Numbrecht, Germany). Immediately thereafter, samples were centrifuged for 10 min at 2000 Â g, with the plasma obtained stored at À808C. Plasma catecholamines were determined by means of high-performance liquid chromatography (HPLC) and electrochemical detection after liquid-liquid extraction [29] . The detection limit was 10 pg/ml and interand intra-assay CVs were <5% for both catecholamines.
Saliva samples were collected in Salivettes (Sarstedt, Rommelsdorf, Germany) and stored at À208C until analysis. Centrifugation of thawed samples was at 3000 Â g for 10 min, resulting in low-viscosity saliva. Salivary free-cortisol concentrations were measured using a commercial chemiluminescence immunoassay (LIA) with a high sensitivity of 0.16 ng/ml (IBL Hamburg, Germany) [30] . Inter-and intra-assay CVs were <11.5 and 7.7%, respectively.
Statistical analyses
Data were analyzed using the SPSS (version 13.0) statistical software package (SPSS Inc., Chicago, Illinois, USA). All tests were two-tailed with level of significance set at P 0.05 and level of borderline significance set at P 0.1. Prior to statistical analyses all data were tested for normality using the Kolmogorov-Smirnov test. BMI was logarithmically transformed and coagulation values were subject to Blom normal score transformation. For reasons of clarity, we provide untransformed data. We used independent-samples t-tests to investigate differences in measures between groups, and the Friedman test to investigate changes in hemodynamic, coagulation and hormone measures across all time points.
Relative change scores in coagulation measures, hormones and hemodynamic factors from rest to immediately after stress were computed by the formula x ¼ (100%/y) Â z, where x ¼ change score (%), y ¼ resting value of a variable, and z ¼ stress value of a variable. To compute the cortisol change score, the cortisol level 10 min after stress (i.e. peak response) was used instead of levels immediately after stress. Calculation of the area under the curve (AUC) for coagulation and hormone measures across all time points followed a previous formula that considers the variable time between measurements and ignores the distance from zero for all measurements, thereby emphasizing the integrated changes over time [31] . Change scores and AUC measures for coagulation factors were computed on original data and transformed thereafter.
Hierarchical linear regression analysis was applied using the enter method whereby none of the models considered more than five independent variables, to prevent model overfitting [32] . Following our previous observations [22] , the optimal total sample size to detect an expected effect size of 0.35 in regression analyses with a power between 0.80 (maximum of five predictors) and 0.95 (minimum of one predictor) was n ¼ 42. We regressed MBP, hormone levels and the interaction thereof in this order on coagulation measures. We then tested whether these relationships would be independent of age and BMI, which were entered first into the equation. In order to reduce problems with multicollinearity, all independent variables were centered to the mean, and centered values of MBP and hormone levels were multiplied to obtain interaction terms [33] . A significant interaction would mean that the slope of the relationship between hormones and coagulation factors is different with high BP (mean centered MBP minus one SD) compared to low BP (mean centered MBP plus one SD). Using the approach described by Holmbeck [34] , we performed post-hoc analyses on interaction terms to determine the relationship between hormones and coagulation factors for low and high MBP values. Post-hoc tests were adjusted for age and BMI to identify the extent to which hormones were related to coagulation factors for high and low MBP values [34] .
We did not perform statistical adjustment for multiple tests because the various coagulation factors differ substantially in their position and function within the coagulation cascade and, moreover, their dynamics are differently affected by different stress hormones, and across the different time intervals assessed [15, 24] . In this case of very specific pre-established hypotheses some authors do not advocate statistical adjustment for multiple tests because this may deem truly important associations insignificant [35] . Table 1 provides the characteristics of the 17 hypertensive subjects and 25 normotensive controls studied. As per definition, hypertensive subjects had higher systolic and diastolic BP than normotensive subjects. In addition, hypertensives had higher BMI, and higher plasma levels of fibrinogen and of norepinehrine at rest (i.e. immediately before stress) than normotensives. Hemodynamic, stress hormone and coagulation reactivity There were significant time effects for hemodynamic measures (P < 0.001; Fig. 1a-c) , stress hormones (P < 0.001; Fig. 1d-f ) and coagulation factors (P < 0.001; Fig. 2a-d) , indicating a significant stress response in all of these variables. Post-hoc analyses revealed that increases in hemodynamic measures, stress hormones and coagulation factors from rest to immediately after stress was significant (all P < 0.001).
Results
Subjects' characteristics
Coagulation activity at rest
Coagulation change from rest to immediately after stress 
Discussion
We found significant interactions between stress hormones and MBP for coagulation measures at rest and with borderline significance, during the entire stress and recovery interval. With high MBP, the slopes of the relationship between resting epinephrine and FVII:C and D-dimer, respectively, and between resting cortisol and D-dimer were significantly different from the respective slopes with low MBP. Examination of the beta coefficients suggests that with high MBP, epinephrine approached a statistically significant relationship with D-dimer (b ¼ 0.23). However, with low MBP, this relationship was much weaker (b ¼ 0.09). Therefore, it appears that epinephrine poses a greater risk for coagulation activity among those with high BP than among those with low BP. Moreover, post-hoc analyses indicate a positive, albeit non-significant, relationship between cortisol and D-dimer (b ¼ 0.10) when MBP is high. But, when MBP is low, the correlation is negative (b ¼ À0. 24) , suggesting that cortisol has some mild effect on coagulation activation among high-BP individuals. Together with the associations between resting epinephrine and FVIII:C levels and between resting norepinephrine and fibrinogen levels, our study suggests that stress hormone activity plays a role in regulating steadystate coagulation activity. Importantly, we found that the effect of resting stress hormones on coagulation factors was dependent in part upon MBP level, but was generally not affected by age and BMI.
We tested the effect of stress hormones on stresstriggered coagulation activation in two different ways: in terms of short-term change from rest to immediately after stress, and in terms of overall reactivity including the recovery period. Performing both these analyses exceeds an exploratory investigation because they track quite different aspects in reactivity of the physiological systems under study. There were no interactions between short-term hormone changes and MBP in terms of any coagulation factor. Nonetheless, a greater amount of acute norepinephrine release predicted a higher level of acute D-dimer formation. This notion is consistent with early studies showing that catecholamine infusion dosedependently elicited hemostatic changes in plasma within minutes [25, 26] consequent to a rapid release of hemostatic molecules from extravascular compartments into the circulation through a b 2 -adrenergic mechanism [15] . Given previous research on greater stress procoagulant reactivity in hypertensives than in normotensives [20, 21] , the negative association between MBP and the increase of FVIII:C from rest to immediately after stress independent of epinephrine and norepinephrine change was rather unexpected. Part of this observation might relate to the confounding effect of age and BMI, being supported by the finding that the expected direct relationship between norepinephrine and D-dimer change became non-significant with adjustment for age and BMI. Counterintuitively, cortisol and FVIII:C change showed an inverse relationship, suggesting that HPA axis activity was associated with a relatively attenuated shortterm FVIII:C response to stress. One explanation of this finding could relate to research showing that endogenous glucocorticoids may suppress SNS activity [36] . Interestingly, in all other analyses, we observed no relationship between cortisol and coagulation activity, either at rest or in relation to acute stress, suggesting that, of the stressmediating systems, the SNS may be of greater importance than the HPA axis in moderating coagulation.
Although not investigated in the present study, sympathetic activation increases platelet activity [20] and decreases fibrinolysis [21] more in hypertensives than in normotensives. It is not known, however, whether such a group difference in thrombogenicity would carry over to recovery from stress. This seems of clinical importance because sustained hypercoagulability during a relatively long period of recovery from stress may be of greater clinical importance than more short-term procoagulant changes rapidly returning to resting levels after stress termination [24] . In contrast to the aforementioned lack of a role of MBP in the relationship between acute changes in stress hormones and coagulation factors, we found that MBP interacted with the integrated release of epinephrine between rest and 1 h after stress in predicting integrated change of FVII:C and of fibrinogen. In addition, MBP interacted with integrated norepinephrine release in predicting integrated FVIII:C change. We note that, although independent of age and BMI, these relationships reached only borderline significance, and must therefore be regarded as preliminary, pending further replication in larger samples. Again corroborating a role for SNS activity in hypercoagulability, norepinephrine spillover between rest and 1 h after stress was directly associated with D-dimer formation during this time interval, with adjustment for covariates rendering this relationship non-significant.
The recruitment of apparently healthy and drug-free subjects with reasonable health habits was a strength of our study, because coagulation is affected by numerous diseases, medication (including antihypertensives) and lifestyle factors [15] . Negligible confounding of our coagulation results was further achieved by considering age and BMI a priori as control variables. We mention four limitations of our study. First, even though catecholamine infusion consistently elicited coagulation activation in previous studies [25, 26] , the significant associations between stress hormones and coagulation factors, as related to MBP, do not prove a causal link in our study. Second, to prevent spurious associations by chance, some investigators would require higher levels of significance than we observed in terms of some associations between stress hormones and coagulation measures. However, it seems acceptable not to adjust for multiple comparisons, given our pre-specified hypotheses [35] . Third, conclusions in terms of whether one stress hormone would affect a particular coagulation factor more specifically than any other must be drawn with caution, given the rather small sample size. Fourth, our findings cannot be generalized to populations other than apparently healthy men with BP in the normotensive and mildly hypertensive range. The role of the SNS for high BP seems most evident in borderline hypertensives [37] , whereas hypercoagulability appears to increase with increasing severity of hypertension and end organ damage [9, 10] , respectively. We were unable to scrutinize a possibly different role of stress hormones in relation to the hypercoagulable state between groups having different severity of hypertension or in women.
To sum up, we found some evidence for our hypothesis that stress hormones affect coagulation activity in relation to screening blood pressure level. This observation appeared to be stronger at rest than in response to acute psychosocial stress. The effect of immediate stress hormone reactivity on coagulation factors was unrelated to BP. Moreover, it is of potential clinical interest that reactivity of hormones predicted coagulation changes during stress recovery depending on screening BP. However, this finding requires replication in larger samples.
